Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

US Patent 8715694 · Granted May 6, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-cancer combination therapies comprising CTLA-4 and PD-1 blocking agents2025
CTLA4 binders2023
PD1/CTLA4 binders2020
CTLA4 binders2019
Substituted triazolo-pyrimidine compounds for modulating cell proliferation, dif2017
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2015
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2015
Recombinant dengue virus antigen comprising the capsid protein leader sequence, 2015
Substituted triazolo-pyrimidine compounds for modulating cell proliferation dif2015
Immunosuppressive polypeptides and nucleic acids2013
Immunosuppressive polypeptides and nucleic acids2013
Immunosuppressive polypeptides and nucleic acids2013